BSX
Boston Scientific CorporationStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.10% · Russell 1000 0.09% · US Stock Market 0.09% · Russell 3000 0.09% · MSCI ACWI 0.08% · MSCI World 0.08%$42.98-0.28%
as of market close, Sep 11, 2026
☾ AH — —
BSX — Boston Scientific Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
20.030.040.050.060.070.080.090.0100.00100.0M$42.98—20162019202120242026
2026-09-11
Price$42.98
MA20$50.55
MA50$76.08
Vol27.0M
Key stats
Price data
- Price
- $42.98
- Change YTD
- -54.92%
- Next earnings
- Oct 28, 2026
- Market cap
- 62.3B
- Enterprise value
- 75.3B
- Shares outstanding
- 1.4B
- 52W low
- $42.20
- 52W high
- $105.72
- From 52W high
- -59.35%
- From 52W low
- +1.85%
- 52W range
- 1%
- Beta
- 0.57
Volume
- Rel volume
- 1.38×
- 30D volume
- 19.6M
- 30D $ vol
- 947.2M
Fundamentals
- Sales (ttm)
- 21B
- Sales/share
- $14.49
- EPS (ttm)
- $2.46
- FCF (ttm)
- 3.6B
- FCF/share
- $2.50
- Book value/share
- $17.20
- Net margin
- 17.47%
- ROE
- 14.72%
- ROA
- 8.11%
- Debt / equity
- 0.44×
- Current ratio
- 1.24
Growth (CAGR, ttm) · 10Y
- Sales
- +13.54%+16.14%+13.40%+9.70%
- Net income
- +46.98%+59.03%+44.53%n/a
- FCF
- +4.02%+33.92%+14.35%+12.96%
- Shares
- -2.20%-0.34%+0.35%+0.63%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +47.04%+57.44%+43.35%n/a
- Sales/share
- +16.09%+16.54%+13.00%+9.01%
- FCF/share
- +6.36%+34.38%+13.95%+12.25%
- Book value/share
- +13.71%+11.38%+8.97%+14.17%
- Dividend/share
- -75.04%-31.44%n/an/a
- Price
- -58.83%-7.64%-0.67%+6.22%
- Total return
- -58.83%-7.64%-0.67%+6.22%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 17.5×
- P/OI (ttm)
- 15.0×
- Fwd P/E
- 13.9×
- P/S (ttm)
- 3.0×
- P/B (mrq)
- 2.5×
- P/FCF (ttm)
- 17.2×
- EV/EBITDA (fy)
- 13.5×
- EV/Sales (ttm)
- 3.6×
- FCF yield (ttm)
- 5.82%
- Buyback yield (realized, 1y)
- 2.20%
- Shareholder yield (realized, 1y)
- 2.20%
- Buyback yield (cash, ttm)
- 3.21%
- Shareholder yield (cash, ttm)
- 3.21%
Vs own 10Y history
- P/E
- 10th
- P/OI
- 0th
- P/S
- 0th
- P/B
- 0th
- P/FCF
- 0th
Bar = where today’s multiple sits in BSX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · windows as of 2026-09-11
1D
-0.28%
5D
-8.46%
1M
-16.41%
3M
-8.88%
YTD
-54.92%
1Y
-59.16%
5Y
-4.32%
Financial statements
Open full BSX financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -8.44% | -0.65% |
| JNJ | Johnson & Johnson | +2.31% | -0.29% |
| ABBV | AbbVie Inc. | +3.36% | +0.83% |
| MRK | Merck & Co. Inc. | +8.28% | -0.54% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -6.53% | -2.37% |
| TMO | Thermo Fisher Scientific Inc. | +1.13% | +1.10% |
| AMGN | Amgen Inc. | -8.80% | -1.34% |
| GILD | Gilead Sciences Inc. | +5.78% | -0.75% |
Boston Scientific Corporation (BSX) trades at $42.98 with a live price and an interactive chart covering 34+ years of daily price history, plus key valuation metrics. ChartRow also publishes BSX’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BSX financial statements →
